Elsevier

Clinical Nutrition

Volume 16, Issue 2, April 1997, Pages 43-55
Clinical Nutrition

ESPEN guidelines for nutrition in liver disease and transplantation

https://doi.org/10.1016/S0261-5614(97)80022-2Get rights and content

First page preview

First page preview
Click to open first page preview

References (168)

  • DolzC. et al.

    Ascites increases the resting energy expenditure in liver cirrhosis

    Gastroenterology

    (1991)
  • PrijatmokoD. et al.

    Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis

    Gastroenterology

    (1993)
  • MasonJ.B. et al.

    The unbearable lightness of being a cirrhotic

    Gastroenterology

    (1993)
  • HeymsfieldS.B. et al.

    Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method

    Am J Clin Nutr

    (1983)
  • PirlichM. et al.

    The validity of the creatinine approach to estimate skeletal muscle mass in patients with liver cirrhosis

    Hepatology

    (1996)
  • ForbesG.B. et al.

    Urinary creatinine excretion and lean body mass

    Am J Clin Nutr

    (1976)
  • ZillikensM.C. et al.

    Whole body and segmental bioelectrical impedance analysis in patients with cirrhosis of the liver: changes after treatment of ascites

    Am J Clin Nutr

    (1992)
  • ZillikensM.C. et al.

    The validity of bioelectrical impedance analysis in estimating total body water in patients with cirrhosis

    J Hepatol

    (1992)
  • MüllerM.J. et al.

    Are patients with liver cirrhosis hypermetabolic?

    Clin Nutr

    (1994)
  • HillG.L.

    Impact of nutritional support on the clinical outcome of the surgical patient

    Clin Nutr

    (1994)
  • Di CeccoS.R. et al.

    Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation

    Mayo Clin Proc

    (1989)
  • O'KeefeS.J. et al.

    Malnutrition and immunoincompetence in patients with liver disease

    Lancet

    (1980)
  • MøllerS. et al.

    Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding

    J Hepatol

    (1994)
  • NasrallahS.M. et al.

    Amino acid therapy of alcoholic hepatitis

    Lancet

    (1980)
  • HoldsworthJ.D. et al.

    Body protein metabolism and plasma amino acids in cirrhosis of the liver. The effect of varying the branched chain amino acid content of intravenous amino acid solutions

    Clin Nutr

    (1984)
  • CampilloB. et al.

    Short-term changes in energy metabolism after 1 month of a regular oral diet in severely malnourished cirrhotic patients

    Metabolism

    (1995)
  • EgbertsE.-H. et al.

    Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double blind placebo-controlled crossover study

    Gastroenterology

    (1985)
  • MarchesiniG. et al.

    Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy

    J Hepatol

    (1990)
  • PlauthM. et al.

    Long-term treatment of latent portosystemic encephalopathy with branched chain amino acids. A double-blind placebo-controlled crossover trial

    J Hepatol

    (1993)
  • WeberF.L. et al.

    Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects

    Gastroenterology

    (1985)
  • MarchesiniG. et al.

    Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis

    Hepatology

    (1996)
  • SokolR.J. et al.

    Multicenter trial of d-α-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis

    Gastroenterology

    (1993)
  • DonaghyA. et al.

    Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease

    Hepatology

    (1995)
  • ScharfJ.-G. et al.

    Insulin-like growth factor-1 serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease

    J Hepatol

    (1996)
  • BucuvalasJ.C. et al.

    Resistance to the growth-promoting and metabolic effects of growth hormone in children with chronic liver disease

    J Pediatr

    (1990)
  • MøllerS. et al.

    Short-term effect of recombinant human growth hormone in patients with alcoholic cirrhosis

    J Hepatol

    (1994)
  • PatekA.J. et al.

    Treatment of cirrhosis of the liver by a nutritious diet and supplements rich in vitamin B complex

    J Clin Invest

    (1941)
  • ChildC.G. et al.

    Surgery and portal hypertension

  • MendenhallC.L. et al.

    Protein calorie malnutrition associated with alcoholic hepatitis

    Am J Med

    (1984)
  • LautzH.U. et al.

    Protein calorie malnutrition in liver cirrhosis

    Clin Invest

    (1992)
  • Italian Multicentre Cooperative Project on nutrition in liver cirrhosis. Nutritional status in cirrhosis

    J Hepatol

    (1994)
  • OrloffM.J. et al.

    Portocaval shunt as emergency procedure in unselected patients with alcoholic cirrhosis

    Surg Gynecol Obstet

    (1975)
  • MüllerM.J. et al.

    Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state

    Hepatology

    (1992)
  • OwenO.E. et al.

    Nature and quantity of fuels consumed in patients with alcoholic cirrhosis

    J Clin Invest

    (1983)
  • MerliM. et al.

    Basal energy production rate and substrate use in stable cirrhotic patients

    Hepatology

    (1990)
  • BianchiG. et al.

    Prognostic significance of diabetes in patients with cirrhosis

    Hepatology

    (1994)
  • MüllerM.J. et al.

    Glucose intolerance in liver cirrhosis: Role of hepatic and non-hepatic influences

    Eur J Clin Chem Clin Biochem

    (1994)
  • SelbergO. et al.

    Insulin resistance in cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism

    J Clin Invest

    (1993)
  • RiggioO. et al.

    Early post prandial energy expenditure and macronutrient use after a mixed meal in cirrhotic patients

    J Parent Enteral Nutr

    (1992)
  • KruszynskaY. et al.

    The relationship between insulin sensitivity and skeletal muscle enzyme activity in hepatic cirrhosis

    Hepatology

    (1988)
  • Cited by (348)

    • Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more?

      2022, Digestive and Liver Disease
      Citation Excerpt :

      The incidence of falls was similar in patients with MHE compared to those without at both CHI2 and logrank test (35%vs15%, CHI2: p = 0.1; logrank test: p = 0.26; HR 1.5 CI95% 0.4–5.7). Skeletal muscle alterations, sarcopenia and/or myosteatosis, are frequently observed in patients with cirrhosis [13] and have been related lower survival rate [12-17] and increased incidence of clinical complications [14,19,22,38]. Falls may have serious consequences in patients with cirrhosis (fractures, morbidity, complications, infections) and are more frequent in cirrhotic patients with cognitive impairment due to MHE which actually may decrease the patients attention and reaction [39-40].

    View all citing articles on Scopus
    View full text